Delivery Order SPE2DB22D1202-SPE2DB25FVMA0
- Not listed
- The Defense Logistics Agency awarded a $6,209.10 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This firm fixed-price, non-set-aside delivery order was awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $68,990 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. The delivery order, issued on September 27, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded without any set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $37,836.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $18,736.79 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-competitive delivery order was issued on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $13,511.84 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric typhoid vaccine supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a delivery against...
- The Defense Logistics Agency awarded a $10,348.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with completion targeted for August 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $24,644.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be executed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,531.20 with a completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,724.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVMA0Delivery Order
The Defense Logistics Agency awarded a $68,990 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This firm fixed-price, competitively awarded contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive portfolio of medications, vaccines, and medical supplies to military and veteran healthcare systems. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to meet federal procurement requirements through open competition. This delivery order for TYPHIM VI vaccine syringes supports the broader mission of the DLA Medical Supply Chain to provide essential pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.0k | 9/22/25 |